Patrick Schweickert
About Patrick Schweickert
Patrick Schweickert is a Senior Scientist at Arcus Biosciences, specializing in oncology and cancer biology. He has a background in biological sciences and has contributed to research on T Cell and NK Cell activity.
Work at Arcus Biosciences
Patrick Schweickert currently serves as a Senior Scientist at Arcus Biosciences, a role he has held since 2022. He previously worked at the same organization as a Biological Scientist from 2020 to 2022. His tenure at Arcus Biosciences has been based in the San Francisco Bay Area. In his current position, he focuses on advancing research initiatives and contributing to the development of innovative cancer therapies.
Education and Expertise
Patrick Schweickert earned a Bachelor of Science (B.S.) in Biology/Biological Sciences from Indiana University Bloomington, where he studied from 2006 to 2010. He furthered his education at Purdue University, obtaining a PhD in Oncology and Cancer Biology between 2013 and 2018. His academic background provides a strong foundation for his research in cancer biology and immunotherapy.
Background
Prior to his current role, Patrick Schweickert spent seven years at Purdue University, where he was a PhD candidate from 2013 to 2020. During this time, he also served as a Graduate Teaching Assistant for three years. In 2017, he gained experience as an Academic Intern at Eli Lilly and Company for five months, which contributed to his professional development in the pharmaceutical industry.
Research Contributions
Patrick Schweickert has been involved in significant research focused on the dual inhibition of DGKα and DGKζ to enhance T Cell and NK Cell activity. His findings in this area contribute to the understanding of immune responses in cancer treatment. He has presented his research at the Society for Immunotherapy of Cancer (SITC) conference, showcasing his work to a broader scientific audience.